CRUZ Tunisia-Multivessel Registry
NCT: NCT06663696 · RECRUITING
Brief Summary
The primary objective of this registry is to evaluate the safety and clinical performance of the biodegradable polymer-coated Supraflex Cruz Sirolimus-eluting Stent (SES) in an unselected, all-comer patient population with multivessel disease. This population represents daily clinical practice and includes patients requiring coronary revascularization with drug-eluting stents (DES).
Frequently Asked Questions
What is CRUZ Tunisia-Multivessel Registry?
CRUZ Tunisia-Multivessel Registry is a clinical trial registered under NCT06663696. Current status: RECRUITING.
What is the status of NCT06663696?
The current status of NCT06663696 (CRUZ Tunisia-Multivessel Registry) is: RECRUITING.
When did CRUZ Tunisia-Multivessel Registry start?
CRUZ Tunisia-Multivessel Registry started on 2024-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.